Machine learning based on radiomics features combing B-mode transrectal ultrasound and contrast-enhanced ultrasound to improve peripheral zone prostate cancer detection

Two-Dimensional Ultrasound-Based Radiomics Nomogram for Diabetic Kidney Disease: A Pilot Study

Objective

To establish a radiomics nomogram based on two-dimensional ultrasound for risk assessment of diabetic kidney disease (DKD) in patients with type 2 diabetes mellitus (T2DM).

Methods

This study retrospectively collected two-dimensional ultrasound images and clinical data from 52 patients with T2DM who underwent renal biopsy in our hospital from January 2023 to August 2023. Based on the pathological results, all patients were categorized into two groups: DKD (n=33) and non-DKD (n=19). The radiomic features of the segmented kidney in ultrasound pictures were retrieved and selected to calculate each patient's rad-score. A predictive nomogram based on rad-score and clinical features was then constructed and validated based on the calibration curve.

Results

The rad-score for all patients were computed based on five imaging characteristics extracted from the ultrasound images. The predictive nomogram was developed with the rad-score, diabetic retinopathy, duration of diabetes, and glycosylated hemoglobin. Moreover, This radiomics nomogram showed outstanding calibration capability, discrimination as well as therapeutic usefulness.

Conclusion

We constructed a nomogram based on two-dimensional ultrasound for DKD in T2DM patientsThe model has been proven to have good predictive performance, showing its potential in identifying DKD in T2DM patients and assisting in making appropriate early interventions.

Reliability of Systematic and Targeted Biopsies versus Prostatectomy

Systematic Biopsy (SBx) has been and continues to be the standard staple for detecting prostate cancer. The more expensive MRI guided biopsy (MRITBx) is a better way of detecting cancer. The prostatectomy can provide an accurate condition of the prostate. The goal is to assess how reliable SBx and MRITBx are vis à vis prostatectomy. Graded Gleason scores are used for comparison. Cohen's Kappa index and logistic regression after binarization of the graded Gleason scores are some of the methods used to achieve our goals. Machine learning methods, such as classification trees, are employed to improve predictability clinically. The Cohen's Kappa index is 0.31 for SBx versus prostatectomy, which means a fair agreement. The index is 0.34 for MRITBx versus prostatectomy, which again means a fair agreement. A direct comparison of SBx versus prostatectomy via binarized graded scores gives sensitivity 0.83 and specificity 0.50. On the other hand, a direct comparison of MRITBx versus prostatectomy gives sensitivity 0.78 and specificity 0.67, putting MRITBx on a higher level of accuracy. The SBx and MRITBx do not yet match the findings of prostatectomy completely, but they are useful. We have developed new biomarkers, considering other pieces of information from the patients, to improve the accuracy of SBx and MRITBx. From a clinical point of view, we provide a prediction model for prostatectomy Gleason grades using classification tree methodology.